Old Point Trust & Financial Services N A’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-500
| Closed | -$7.06K | – | 517 |
|
2024
Q1 | $7.06K | Buy |
+500
| New | +$7.06K | ﹤0.01% | 316 |
|
2022
Q3 | – | Sell |
-11,650
| Closed | -$88K | – | 79 |
|
2022
Q2 | $88K | Sell |
11,650
-28,900
| -71% | -$218K | 0.04% | 78 |
|
2022
Q1 | $381K | Sell |
40,550
-1,400
| -3% | -$13.2K | 0.16% | 61 |
|
2021
Q4 | $336K | Sell |
41,950
-600
| -1% | -$4.81K | 0.14% | 63 |
|
2021
Q3 | $414K | Sell |
42,550
-6,100
| -13% | -$59.4K | 0.18% | 57 |
|
2021
Q2 | $482K | Sell |
48,650
-3,500
| -7% | -$34.7K | 0.21% | 57 |
|
2021
Q1 | $602K | Buy |
52,150
+7,400
| +17% | +$85.4K | 0.28% | 52 |
|
2020
Q4 | $432K | Sell |
44,750
-500
| -1% | -$4.83K | 0.22% | 53 |
|
2020
Q3 | $408K | Hold |
45,250
| – | – | 0.22% | 55 |
|
2020
Q2 | $558K | Buy |
45,250
+1,500
| +3% | +$18.5K | 0.31% | 53 |
|
2020
Q1 | $393K | Sell |
43,750
-4,250
| -9% | -$38.2K | 0.25% | 53 |
|
2019
Q4 | $470K | Sell |
48,000
-9,900
| -17% | -$96.9K | 0.22% | 59 |
|
2019
Q3 | $398K | Sell |
57,900
-2,305
| -4% | -$15.8K | 0.19% | 61 |
|
2019
Q2 | $556K | Sell |
60,205
-900
| -1% | -$8.31K | 0.28% | 56 |
|
2019
Q1 | $958K | Buy |
61,105
+1,200
| +2% | +$18.8K | 0.5% | 49 |
|
2018
Q4 | $923K | Buy |
59,905
+5,000
| +9% | +$77K | 0.54% | 47 |
|
2018
Q3 | $1.18M | Buy |
54,905
+6,852
| +14% | +$148K | 0.61% | 46 |
|
2018
Q2 | $1.17M | Buy |
48,053
+5,000
| +12% | +$122K | 0.64% | 46 |
|
2018
Q1 | $736K | Sell |
43,053
-6,350
| -13% | -$109K | 0.42% | 53 |
|
2017
Q4 | $937K | Sell |
49,403
-4,102
| -8% | -$77.8K | 0.51% | 52 |
|
2017
Q3 | $942K | Buy |
53,505
+5,000
| +10% | +$88K | 0.53% | 50 |
|
2017
Q2 | $1.61M | Sell |
48,505
-100
| -0.2% | -$3.32K | 0.93% | 38 |
|
2017
Q1 | $1.56M | Buy |
48,605
+4,200
| +9% | +$135K | 0.9% | 39 |
|
2016
Q4 | $1.61M | Sell |
44,405
-950
| -2% | -$34.4K | 0.96% | 37 |
|
2016
Q3 | $2.09M | Buy |
45,355
+150
| +0.3% | +$6.9K | 1.28% | 29 |
|
2016
Q2 | $2.27M | Sell |
45,205
-850
| -2% | -$42.7K | 1.41% | 29 |
|
2016
Q1 | $2.46M | Sell |
46,055
-50
| -0.1% | -$2.68K | 1.54% | 27 |
|
2015
Q4 | $3.03M | Buy |
46,105
+1,900
| +4% | +$125K | 1.97% | 23 |
|
2015
Q3 | $2.5M | Sell |
44,205
-550
| -1% | -$31.1K | 1.77% | 23 |
|
2015
Q2 | $2.65M | Buy |
44,755
+1,200
| +3% | +$70.9K | 1.72% | 26 |
|
2015
Q1 | $2.71M | Buy |
43,555
+5
| +0% | +$311 | 1.75% | 26 |
|
2014
Q4 | $2.51M | Buy |
43,550
+1,300
| +3% | +$74.8K | 1.51% | 28 |
|
2014
Q3 | $2.27M | Buy |
42,250
+3,950
| +10% | +$212K | 1.36% | 28 |
|
2014
Q2 | $2.01M | Buy |
38,300
+1,400
| +4% | +$73.4K | 1.2% | 31 |
|
2014
Q1 | $1.95M | Buy |
+36,900
| New | +$1.95M | 1.22% | 31 |
|